
    
      In this long-term follow-up study, no new subjects will be recruited. All subjects
      participating in this long-term follow-up study should have already participated in a
      previous study. No vaccine will be administered during the persistence phase of the study.

      This Protocol Posting has been updated following Protocol amendment 3, September 2009.
    
  